To encourage and develop on a state wide basis educational programs for those persons interested in the field of respiratory care.
To advance the science, technology, ethics and art of respiratory care through institutes, meetings, lectures, educational opportunities and the preparation and distribution of a newsletter and other materials.
To facilitate cooperation between respiratory care personnel and the medical profession, hospitals, service companies, industry, and other agencies within the state interested in respiratory care.
Department Showcase - OctoberThe NSRC is proud to present this month’s Respiratory Showcase, Mary Lanning Memorial Hospital-Cardiopulmonary Services.Mary Lanning Memorial Hospital is located in south central Nebraska’s Adams County in the town of Hastings, population nearly 33,000. Mary Lanning Memorial Hospital was established over 85 years ago by Mr. and Mrs. William H. Lanning after their only child, Mary, died of pneumonia at the age of 21. Because of this tragedy, the Lanning’s felt that people needing medical care should be able to obtain it from a hospital close to home. Mary Lanning Memorial Hospital has continued the Lanning’s goal throughout the years continuing expansion...
Department Showcase - SeptemberThe NSRC is proud to announce this month’s Respiratory Showcase, Community Hospital-Respiratory Care Department in McCook.Community Hospital is located in McCook, Nebraska. McCook is a small farming community with a population of 8,000 people. It serves the southwest Nebraska area as one of the largest critical access hospitals in the region. The Respiratory Care department consists of four fulltime and one part time respiratory therapists, as well as one fulltime and one part time registered nurse. We administer routine floor care, BIPAP Therapy, ventilator management, as well as pulmonary rehabilitation services. Our diagnostics include ABGs, ECGs, Holters, Cardiac event... Read More...
Become an NSRC & AARC Member Today!The NSRC would like to inform you of a unique membership program that allows you to save $$$ and support your profession! AARC Membership vouchers are available for both NEW & RENEWAL memberships! The program allows individuals to purchase membership vouchers directly from the NSRC. The cost of the vouchers is $75.00—an 18% savings when compared to direct AARC membership!Buy a voucher and submit it with any NEW AARC Membership Application or Renewal notice. Contact Jeff Gonzalez at jgonzalez@neheart.com to purchase a voucher or for more information!
Cortex Pharmaceuticals, Inc. (NYSE Alternext US (COR)) reported that top-line data from its second Phase IIa study in opioid-induced respiratory depression (RD) demonstrated that a single oral dose of 1500mg of the AMPAKINE® compound CX717 achieved statistical significance (p = 0.005) over placebo on the primary endpoint measure of spontaneous basal respiration without affecting opioid-induced analgesia.
Allergic reactions to latex happen commonly in medical settings, where rubber gloves are in abundant supply. But less-visible elements in other environments can also pose danger, according to the American Academy of Allergy, Asthma & Immunology (AAAAI). "Consider that restaurant meals are frequently prepared by cooks wearing latex gloves. In schools, the cafeteria may be a threat, but there is also potential exposure to latex in school supplies," said Donald H.
Asthmatic children whose parents have high expectations for their ability to function normally are less likely to have symptoms than other children dealing with the condition, according to a new study. Children also are more likely to use asthma controller medications appropriately if they have a routine for taking medicine and if their parents clearly understand how well symptoms can be controlled. The study, which appears in the Oct. 2008 issue of
Genentech, Inc. (NYSE:DNA) and OSI Pharmaceuticals, Inc. (Nasdaq:OSIP) today announced that a randomized Phase III study (BeTa Lung) evaluating Avastin® (bevacizumab) in combination with Tarceva® (erlotinib) in patients with advanced non-small cell lung cancer (NSCLC) whose disease had progressed following platinum-based chemotherapy did not meet its primary endpoint of improving overall survival compared to Tarceva in combination with placebo.
